Incorporation of zebularine from its 2′-deoxyribonucleoside triphosphate derivative and activity as a template-coding nucleobase

Nucleosides, Nucleotides and Nucleic Acids

Volumn 27, Issue 2, 2008, Pages 131-145

  Dowd, Casimir L ^a   Sutch, Brian T ^b   Haworth, Ian S ^b   Eritja, Ramón ^c   Marquez, Victor E ^d   Yang, Allen S ^a,e  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c INSTITUT DE BIOLOGIA MOLECULAR DE BARCELONA   (Spain)

^d NATIONAL CANCER INSTITUTE   (United States)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

5 Azacytidine; DNA methylation; Epigenetics; Zebularine

Indexed keywords

ADENINE; CYTOSINE; DEOXYRIBONUCLEOSIDE TRIPHOSPHATE; GUANINE; HYPOXANTHINE; METHYLTRANSFERASE; ZEBULARINE;

ARTICLE; BASE PAIRING; COMPUTER MODEL; DNA METHYLATION; DNA TEMPLATE; DRUG STRUCTURE; ENZYME INHIBITION; EPIGENETICS; NUCLEOTIDE SEQUENCE; SEQUENCE ANALYSIS;

BASE PAIRING; CYTIDINE; ENZYME INHIBITORS; MODELS, MOLECULAR; OLIGONUCLEOTIDES; SEQUENCE ANALYSIS, DNA; SITE-SPECIFIC DNA METHYLTRANSFERASE (CYTOSINE-SPECIFIC);

EID: 38349099042     PISSN: 15257770     EISSN: 15322335     Source Type: Journal    
DOI: 10.1080/15257770701795888     Document Type: Article

References (40)

1. Jones, P.A.; Baylin, S.B. The fundamental role of epigenetic events in cancer. Nat. Rev. Genet. 2002, 3(6), 415-428.
2. Bestor, T.H.; Verdine, G.L. DNA methyltransferases. Curr. Opin. Cell Biol. 1994, 6(3), 380-389.
3. Klimasauskas, S.; Kumar, S.; Roberts, R.J.; Cheng, X. HhaI methyltransferase flips its target base out of the DNA helix. [See comment]. Cell 1994, 76(2), 357-369.
4. Wu, J.C.; Santi, D.V. Kinetic and catalytic mechanism of HhaI methyltransferase. J. Biol. Chem. 1987, 262(10), 4778-4786.
5. Smith, S.S.; Kaplan, B.E.; Sowers, L.C.; Newman, E.M. Mechanism of human methyl-directed DNA methyltransferase and the fidelity of cytosine methylation. Proc. Natl. Acad. Sci. USA 1992, 89(10), 4744-4748.
6. Brank, A.S.; Eritja, R.; Garcia, R.G.; Marquez, V.E.; Christman, J.K. Inhibition of HhaI DNA (Cytosine-C5) methyltransferase by oligodeoxyribonucleotides containing 5-aza-2-deoxycytidine: examination of the intertwined roles of co-factor, target, transition state structure and enzyme conformation. J. Mol. Biol. 2002, 323(1), 53-67.
7. Christman, J.K. 5-Azacytidine and 5-aza-2′-deoxycytidine as inhibitors of DNA methylation: mechanistic studies and their implications for cancer therapy. Oncogene 2002, 21(35), 5483-5495.
8. Jones, P.A.; Taylor, S.M. Cellular differentiation, cytidine analogs and DNA methylation. Cell 1980, 20(1), 85-93.
9. Glover, A.B.; Leyland-Jones, B.R.; Chun, H.G.; Davies, B.; Hoth, D.F. Azacitidine: 10 years later. Cancer Treat. Rep. 1987, 71(7-8), 737-746.
10. Gilbert, J.; Gore, S.D.; Herman, J.G.; Carducci, M.A. The clinical application of targeting cancer through histone acetylation and hypomethylation. Clin. Cancer Res. 2004, 10(14), 4589-4596.
11. Santini, V.; Kantarjian, H.M.; Issa, J.P. Changes in DNA methylation in neoplasia: pathophysiology and therapeutic implications. Ann. Intern. Med. 2001(7), 573-586.
12. Silverman, L.R.; Demakos, E.P.; Peterson, B.L.; et al. Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: a study of the cancer and leukemia group B. [See comment]. J. Clin. Oncol. 2002, 20(10), 2429-2440.
13. Wijermans, P.; Lubbert, M.; Verhoef, G.; et al. Low-dose 5-aza-2′-deoxycytidine, a DNA hypomethylating agent, for the treatment of high-risk myelodysplastic syndrome: a multicenter phase II study in elderly patients. J. Clin. Oncol. 2000, 18(5), 956-962.
14. Issa, J.J.; Garcia-Manero, G.; Giles, F.J.; et al. Phase 1 study of low-dose prolonged exposure schedules of the hypomethylating agent 5-aza-2′-deoxycytidine (decitabine) in hematopoietic malignancies. Blood 2004, 103(5), 1635-1640.
15. Cheng, J.C.; Matsen, C.B.; Gonzales, F.A.; et al. Inhibition of DNA methylation and reactivation of silenced genes by zebularine. J. Natl. Cancer Inst. 2003, 95(5), 399-409.
16. Cheng, J.C.; Weisenberger, D.J.; Gonzales, F.A.; et al. Continuous zebularine treatment effectively sustains demethylation in human bladder cancer cells. Mol. Cell Biol. 2004, 24(3), 1270-1278.
17. Holleran, J.L.; Parise, R.A.; Joseph, E.; et al. Plasma pharmacokinetics, oral bioavailability, and interspecies scaling of the DNA methyltransferase inhibitor, zebularine. Clin. Cancer Res. 2005, 11(10), 3862-3868.
18. Klecker, R.W.; Cysyk, R.L.; Collins, J.M. Zebularine metabolism by aldehyde oxidase in hepatic cytosol from humans, monkeys, dogs, rats and mice: Influence of sex and inhibitors. Bioorg. Med. Chem. 2006, 14, 62-66.
19. Zhou, L.; Cheng, X.; Connolly, B.A.; Dickman, M.J.; Hurd, P.J.; Hornby, D.P. Zebularine: a novel DNA methylation inhibitor that forms a covalent complex with DNA methyltransferases. J. Mol. Biol. 2002, 321(4), 591-599.
20. Ford, K.; Taylor, C.; Connolly, B.; Hornby, D.P. Effects of co-factor and deoxycytidine substituted oligonucleotides upon sequence-specific interactions between MspI DNA methyltransferase and DNA. J. Mol. Biol. 1993, 230(3), 779-786.
21. Hurd, P.J.; Whitmarsh, A.J.; Baldwin, G.S.; et al. Mechanism-based inhibition of C5-cytosine DNA methyltransferases by 2-H pyrimidinone. J. Mol. Biol. 1999, 286(2), 389-401.
22. Marquez, V.E.; Eritja, R.; Kelley, J.A.; Vanbemmel, D.; Christman, J.K. Potent inhibition of HhaI DNA methylase by the aglycon of 2-(1H)-pyrimidinone riboside (zebularine) at the GCGC recognition domain. Ann. NY Acad. Sci. 2003, 1002, 154-164.
23. Ben-Kasus, T.; Ben-Zvi, Z.; Marquez, V.; Kelley, J.; Agbaria, R. Metabolic activation of zebularine, a novel DNA methylation inhibitor, in human bladder carcinoma cells. Biochem. Pharmacol. 2005, 70, 121-133.
24. Charczuk, R.; Tamm, C.; Suri, B.; Bickle, T. An unusual base pairing between pyrimidine and pyridine nucleotides. Nucleic Acids Res. 1986, 14(23), 9530.
25. Shen, J.C.; Creighton, S.; Jones, P.A.; Goodman, M.F. A comparison of the fidelity of copying 5-methylcytosine and cytosine at a defined DNA template site. Nucleic Acids Res. 1992, 20(19), 5119-5125.
26. Vives, M.; Eritja, R.; Tauler, R.; Marquez, V.E.; Gargallo, R. Synthesis, stability, and protonation studies of a self-complementary dodecamer containing the modified nucleoside 2′-deoxyzebularine. Biopolymers 2004, 73(1), 27-43.
27. Barchi, J.J. Jr.; Cooney, D.A.; Hao, Z.; et al. Improved synthesis of zebularine [1-(beta-D-ribofuranosyl)-dihydropyrimidin-2-one]nucleotides as inhibitors of human deoxycytidylate deaminase. J. Enzyme Inhib. 1995, 9(2), 147-162.
28. Ronaghi, M. Pyrosequencing sheds light on DNA sequencing. Genome Res. 2001, 11(1), 3-11.
29. Ronaghi, M.; Karamohamed, S.; Pettersson, B.; Uhlen, M.; Nyren, P. Real-time DNA sequencing using detection of pyrophosphate release. Anal. Biochem. 1996, 242(1), 84-89.
30. Ahmadian, A.; Gharizadeh, B.; Gustafsson, A.C.; et al. Single-nucleotide polymorphism analysis by pyrosequencing. Anal. Biochem. 2000, 280(1), 103-110.
31. Ronaghi, M. Pyrosequencing for SNP genotyping. Methods Mol. Biol. 2003, 212, 189-195.
32. Chambers, E.J.; Price, E.A.; Bayramyan, M.Z.; Haworth, I.S. Computation of DNA backbone conformations. J. Biomol. Struct. Dyn. 2003, 21(1), 111-125.
33. Case DA, Darden TA, Cheatham I.T.E.; et al. AMBER 8. In. San Francisco, University of California; 2004.
34. Leeds, J.M.; Slabaugh, M.B.; Mathews, C.K. DNA precursor pools and ribonucleotide reductase activity: distribution between the nucleus and cytoplasm of mammalian cells. Mol. Cell. Biol. 1985, 5(12), 3443-3450.
35. Eritja, R.; Horowitz, D.M.; Walker, P.A.; et al. Synthesis and properties of oligonucleotides containing 2′-deoxynebularine and 2′-deoxyxanthosine. Nucleic Acids Res. 1986, 14(20), 8135-8153.
36. Kool, E.T.; Morales, J.C.; Guckian, K.M. Mimicking the structure and function of DNA: Insights into DNA stability and replication. Angew Chem. Int. Ed. 2000, 39(6), 990-1009.
37. Chiaramonte, M.; Moore, C.L.; Kincaid, K.; Kuchta, R.D. Facile polymerization of dNTPs bearing unnatural base analogues by DNA polymerase alpha and Klenow fragment (DNA polymerase I). Biochemistry 2003, 42(35), 10472-10481.
38. Shen, J.C.; Creighton, S.; Jones, P.A.; Goodman, M.F. A comparison of the fidelity of copying 5-methylcytosine and cytosine at a defined DNA template site. Nucleic Acids Res. 1992, 20(19), 5119-5125.
39. Gowher, H.; Jeltsch, A. Mechanism of inhibition of DNA methyltransferases by cytidine analogs in cancer therapy. Cancer Biol. Ther. 2004, 3(11), 1062-10628.
40. Lee, G.; Wolff, E.; Miller, J.H. Mutagenicity of the cytidine analog zebularine in Escherichia coli. DNA Repair (Amst.) 2004, 3(2), 155-161.